keyword
https://read.qxmd.com/read/38689822/the-potential-role-of-chronic-pain-and-the-polytrauma-clinical-triad-in-predicting-prodromal-pd-a-cross-sectional-study-of-u-s-veterans
#21
JOURNAL ARTICLE
Lee E Neilson, Nadir M Balba, Jonathan E Elliott, Gregory D Scott, Scott D Mist, Matthew P Butler, Mary M Heinricher, Miranda M Lim
INTRODUCTION: The research criteria for prodromal Parkinson disease (pPD) depends on prospectively validated clinical inputs with large effect sizes and/or high prevalence. Neither traumatic brain injury (TBI), post-traumatic stress disorder (PTSD), nor chronic pain are currently included in the calculator, despite recent evidence of association with pPD. These conditions are widely prevalent, co-occurring, and already known to confer risk of REM behavior disorder (RBD) and PD. Few studies have examined PD risk in the context of TBI and PTSD; none have examined chronic pain...
2024: Clinical parkinsonism & related disorders
https://read.qxmd.com/read/38689444/reliability-of-pediatric-rome-iv-criteria-for-the-diagnosis-of-disorders-of-gut-brain-interaction
#22
JOURNAL ARTICLE
Lee Ginton, Rasmita Budhathoki, Miguel Saps
BACKGROUND: The diagnosis of disorders of gut-brain interaction (DGBI) in children is exclusively based on clinical criteria called the Rome criteria. The inter-rater reliability (IRR) measures how well two raters agree with a diagnosis using the same diagnostic tool. Previous versions of the Rome criteria showed only fair to moderate IRR. There have been no studies assessing the IRR of the current edition of the pediatric Rome criteria (Rome IV). This study sought to investigate the IRR of the pediatric Rome IV criteria and compare its reliability with the previous versions of the Rome criteria...
April 30, 2024: Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society
https://read.qxmd.com/read/38689428/short-and-long-term-reproducibility-of-body-surface-gastric-mapping-using-the-gastric-alimetry%C3%A2-system
#23
JOURNAL ARTICLE
Mikaela Law, Gabriel Schamberg, Armen Gharibans, Gabrielle Sebaratnam, Daphne Foong, Chris Varghese, India Fitt, Charlotte Daker, Vincent Ho, Peng Du, Christopher N Andrews, Greg O'Grady, Stefan Calder
BACKGROUND: Many diagnostic tests for gastroduodenal symptoms, such as gastric emptying scintigraphy (GES), gastric emptying breath tests (GEBT), and electrogastrography (EGG) show variable intra-individual reproducibility over time. This study investigated the short- and long-term reproducibility of body surface gastric mapping (BSGM), a non-invasive test for assessing gastric function, in controls and patients with chronic gastroduodenal disorders. METHODS: Participants completed three standardized BSGM tests using Gastric Alimetry® (Alimetry, New Zealand)...
April 30, 2024: Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society
https://read.qxmd.com/read/38689273/the-efficacy-of-real-versus-sham-external-trigeminal-nerve-stimulation-etns-in-youth-with-attention-deficit-hyperactivity-disorder-adhd-over-4-weeks-a-protocol-for-a-multi-centre-double-blind-randomized-parallel-group-phase-iib-study-attens
#24
JOURNAL ARTICLE
Katya Rubia, Lena Johansson, Ben Carter, Dominic Stringer, Paramala Santosh, Mitul A Mehta, Aldo Alberto Conti, Natali Bozhilova, Irem Ece Eraydin, Samuele Cortese
BACKGROUND: Attention Deficit/Hyperactivity Disorder (ADHD), if severe, is usually treated with stimulant or non-stimulant medication. However, users prefer non-drug treatments due to side effects. Alternative non-medication treatments have so far only shown modest effects. External trigeminal nerve stimulation (eTNS) is a minimal risk, non-invasive neuromodulation device, targeting the trigeminal system. It was approved for ADHD in 2019 by the USA Food and Drug administration (FDA) based on a small proof of concept randomised controlled trial (RCT) in 62 children with ADHD showing improvement of ADHD symptoms after 4 weeks of nightly real versus sham eTNS with minimal side effects...
April 30, 2024: BMC Psychiatry
https://read.qxmd.com/read/38689231/early-changes-in-cardiac-troponin-t-and-nt-probnp-levels-in-neonates-receiving-ecmo-support-a-single-center-experience
#25
JOURNAL ARTICLE
Wen-Peng Xie, Yi-Nan Liu, Ya-Ting Zeng, Yi-Rong Zheng, Qiang Chen
OBJECTIVE: This study aimed to examine the changes in absolute value and decline rate of early serum cardiac troponin T (cTnT) and N-terminal pro b-type natriuretic peptide (NT-proBNP) in neonates who received veno-arterial (V-A) extracorporeal membrane oxygenation (ECMO) support therapy within the first week of life. METHODS: We retrospectively collected clinical data and laboratory test results of 18 neonates who underwent V-A ECMO support within one week of birth, from July 2021 to June 2023, using the electronic medical record system...
April 30, 2024: BMC Cardiovascular Disorders
https://read.qxmd.com/read/38689102/pineocytoma-in-a-child-with-pallister-killian-syndrome-a-case-report-and-review-of-the-literature
#26
JOURNAL ARTICLE
Lucia De Martino, Carmela Russo, Delfina Bifano, Lucia Quaglietta, Pietro Spennato, Giuseppe Cinalli
Pallister-Killian syndrome (PKS; OMIM #601803) is a rare genetic disorder typically characterized by developmental delay, seizures, sparse temporal hair, and facial dysmorphisms. PKS is most frequently caused by mosaic supernumerary isochromosome 12p. Here, we report a 27-month-old girl with a prenatal diagnosis of PKS and a histopathological diagnosis of pineocytoma.
April 30, 2024: Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery
https://read.qxmd.com/read/38688894/mitochondrial-antioxidant-elamipretide-improves-learning-and-memory-impairment-induced-by-chronic-sleep-deprivation-in-mice
#27
JOURNAL ARTICLE
Yue-Ming Zhang, Ya-Tao Wang, Ru-Meng Wei, Xue-Yan Li, Bao-Ling Luo, Jing-Ya Zhang, Kai-Xuan Zhang, Shi-Kun Fang, Xue-Chun Liu, Gui-Hai Chen
BACKGROUND: The inflammation and synaptic dysfunction induced by mitochondrial dysfunction play essential roles in the learning and memory impairment associated with sleep dysfunction. Elamipretide (SS-31), a novel mitochondrion-targeted antioxidant, was proven to improve mitochondrial dysfunction, the inflammatory response, synaptic dysfunction, and cognitive impairment in models of cerebral ischemia, sepsis, and type 2 diabetes. However, the potential for SS-31 to improve the cognitive impairment induced by chronic sleep deprivation (CSD) and its underlying mechanisms is unknown...
May 2024: Brain and Behavior
https://read.qxmd.com/read/38688882/clinical-predictors-of-alzheimer-s-disease-like-brain-atrophy-in-individuals-with-memory-complaints
#28
JOURNAL ARTICLE
Ahmet Alp Karakasli, Esra Ozkan, Melike Karacam Dogan, Duygu Cap, Ayca Karaosmanoglu, Sevilay Karahan, Nabi Zorlu, Esen Saka, Yavuz Ayhan
OBJECTIVES: The definition and assessment methods for subjective cognitive decline (SCD) vary among studies. We aimed to investigate which features or assessment methods of SCD best predict Alzheimer's disease (AD)-related structural atrophy patterns. METHODS: We assessed 104 individuals aged 55+ with memory complaints but normal cognitive screening. Our research questions were as follows: To improve the prediction of AD related morphological changes, (1) Would the use of a standardized cognitive screening scale be beneficial? (2) Is conducting a thorough neuropsychological evaluation necessary instead of relying solely on cognitive screening tests? (3) Should we apply SCD-plus research criteria, and if so, which criterion would be the most effective? (4) Is it necessary to consider medical and psychiatric comorbidities, vitamin deficiencies, vascular burden on MRI, and family history? We utilized Freesurfer to analyze cortical thickness and regional brain volume meta-scores linked to AD or predicting its development...
May 2024: Brain and Behavior
https://read.qxmd.com/read/38688878/misperception-of-body-verticality-in-neurological-disorders-a-systematic-review-and-meta-analysis
#29
REVIEW
Esteban Obrero-Gaitán, David Fuentes-Núñez, María Del Moral-García, María Del Carmen López-Ruiz, Daniel Rodríguez-Almagro, Rafael Lomas-Vega
INTRODUCTION: The internal representation of verticality could be disturbed when a lesion in the central nervous system (CNS) affects the centers where information from the vestibular, visual, and/or somatosensory systems, increasing the risk of falling. OBJECTIVE: The aim was to evaluate the vestibular and somatosensory contribution to the verticality pattern in patients with stroke and other neurological disorders. METHODS: A literature search was performed in PubMed, Scopus, Web of Science, and CINAHL databases...
May 2024: Brain and Behavior
https://read.qxmd.com/read/38688785/efficacy-of-deep-brain-stimulation-for-tourette-syndrome-and-its-comorbidities-a-meta-analysis
#30
JOURNAL ARTICLE
Anyi Zhang, Tinghong Liu, Jinshan Xu, Qing Zhao, Xianbin Wang, Zhongliang Jiang, Shuli Liang, Yonghua Cui, Ying Li
Tourette Syndrome (TS) is a neurodevelopmental disorder characterized by multiple motor and vocal tics, often accompanied by comorbid disorders. Optional treatments for patients with TS include behavioral therapy, pharmacotherapy, and neurostimulation techniques. Deep brain stimulation (DBS) has been considered a therapeutic approach for refractory TS and its comorbid symptoms. However, systematic comparison is necessary to understand the therapeutic effect of DBS among patients with TS with various comorbid symptoms, demographic characteristics, or stimulation targets...
April 29, 2024: Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics
https://read.qxmd.com/read/38688675/repurposing-of-dextromethorphan-as-an-adjunct-therapy-in-patients-with-major-depressive-disorder-a-randomised-group-sequential-adaptive-design-controlled-clinical-trial-protocol
#31
RANDOMIZED CONTROLLED TRIAL
Shampa Maji, Debadatta Mohapatra, Monalisa Jena, Anand Srinivasan, Rituparna Maiti
BACKGROUND: Therapeutic latency, lack of efficacy and adverse drug reactions are the major concerns in current antidepressant therapies. To overcome these treatment hurdles, add-on therapy to conventional antidepressant medications may lead to better therapeutic outcomes. The present randomised controlled trial has been planned to evaluate the efficacy and safety of add-on dextromethorphan to selective serotonin reuptake inhibitors (SSRIs) in major depressive disorder (MDD). METHODS AND ANALYSIS: A randomised, double-blind, add-on, placebo-controlled, group sequential design clinical trial will be conducted on patients with MDD who will be randomly assigned to the control and the test group in a 1:1 ratio...
April 30, 2024: BMJ Open
https://read.qxmd.com/read/38688436/the-5-ht-7-receptor-antagonist-sb-269970-ameliorates-maternal-fluoxetine-exposure-induced-impairment-of-synaptic-plasticity-in-the-prefrontal-cortex-of-the-offspring-female-mice
#32
JOURNAL ARTICLE
Bartosz Bobula, Magdalena Kusek, Grzegorz Hess
The use of a selective serotonin reuptake inhibitor fluoxetine in depression during pregnancy and the postpartum period might increase the risk of affective disorders and cognitive symptoms in progeny. In animal models, maternal exposure to fluoxetine throughout gestation and lactation negatively affects the behavior of the offspring. Little is known about the effects of maternal fluoxetine on synaptic transmission and plasticity in the offspring cerebral cortex. During pregnancy and lactation C57BL/6J mouse dams received fluoxetine (7...
April 28, 2024: Pharmacology, Biochemistry, and Behavior
https://read.qxmd.com/read/38688140/physiological-and-chaos-effect-on-dynamics-of-neurological-disorder-with-memory-effect-of-fractional-operator-a-mathematical-study
#33
JOURNAL ARTICLE
Anum Zehra, Parvaiz Ahmad Naik, Ali Hasan, Muhammad Farman, Kottakkaran Sooppy Nisar, Faryal Chaudhry, Zhengxin Huang
BACKGROUND AND OBJECTIVE: To study the dynamical system, it is necessary to formulate the mathematical model to understand the dynamics of various diseases that are spread worldwide. The main objective of our work is to examine neurological disorders by early detection and treatment by taking asymptomatic. The central nervous system (CNS) is impacted by the prevalent neurological condition known as multiple sclerosis (MS), which can result in lesions that spread across time and place...
April 24, 2024: Computer Methods and Programs in Biomedicine
https://read.qxmd.com/read/38688139/exploring-the-disruptions-of-the-neurophysiological-organization-in-alzheimer-s-disease-an-integrative-approach
#34
JOURNAL ARTICLE
Víctor Gutiérrez-de Pablo, Jesús Poza, Aarón Maturana-Candelas, Víctor Rodríguez-González, Miguel Ángel Tola-Arribas, Mónica Cano, Hideyuki Hoshi, Yoshihito Shigihara, Roberto Hornero, Carlos Gómez
BACKGROUND AND OBJECTIVE: Alzheimer's disease (AD) is a neurological disorder that impairs brain functions associated with cognition, memory, and behavior. Noninvasive neurophysiological techniques like magnetoencephalography (MEG) and electroencephalography (EEG) have shown promise in reflecting brain changes related to AD. These techniques are usually assessed at two levels: local activation (spectral, nonlinear, and dynamic properties) and global synchronization (functional connectivity, frequency-dependent network, and multiplex network organization characteristics)...
April 24, 2024: Computer Methods and Programs in Biomedicine
https://read.qxmd.com/read/38688105/neurosurgical-neuromodulation-therapy-for-psychiatric-disorders
#35
REVIEW
Manish Ranjan, James J Mahoney, Ali R Rezai
Psychiatric disorders are among the leading contributors to global disease burden and disability. A significant portion of patients with psychiatric disorders remain treatment-refractory to best available therapy. With insights from the neurocircuitry of psychiatric disorders and extensive experience of neuromodulation with deep brain stimulation (DBS) in movement disorders, DBS is increasingly being considered to modulate the neural network in psychiatric disorders. Currently, obsessive-compulsive disorder (OCD) is the only U...
April 29, 2024: Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics
https://read.qxmd.com/read/38687769/emerging-roles-of-long-non-coding-rnas-in-human-epilepsy
#36
REVIEW
Fatemeh Yazarlou, Leonard Lipovich, Jeffrey A Loeb
Genome-scale biological studies conducted in the post-genomic era have revealed that two-thirds of human genes do not encode proteins. Most functional non-coding RNA transcripts in humans are products of long non-coding RNA (lncRNA) genes, an abundant but still poorly understood class of human genes. As a result of their fundamental and multitasking regulatory roles, lncRNAs are associated with a wide range of human diseases, including neurological disorders. Approximately 40% of lncRNAs are specifically expressed in the brain, and many of them exhibit distinct spatiotemporal patterns of expression...
April 30, 2024: Epilepsia
https://read.qxmd.com/read/38687609/from-the-gut-to-the-brain-the-long-journey-of-phenolic-compounds-with-neurocognitive-effects
#37
JOURNAL ARTICLE
Inés Domínguez-López, Anallely López-Yerena, Anna Vallverdú-Queralt, Mercè Pallàs, Rosa M Lamuela-Raventós, Maria Pérez
The human gut microbiota is a complex community of micro-organisms that play a crucial role in maintaining overall health. Recent research has shown that gut microbes also have a profound impact on brain function and cognition, leading to the concept of the gut-brain axis. One way in which the gut microbiota can influence the brain is through the bioconversion of polyphenols to other bioactive molecules. Phenolic compounds are a group of natural plant metabolites widely available in the human diet, which have anti-inflammatory and other positive effects on health...
April 30, 2024: Nutrition Reviews
https://read.qxmd.com/read/38687608/dietary-dicarboxylic-acids-provide-a-non-storable-alternative-fat-source-that-protects-mice-against-obesity
#38
JOURNAL ARTICLE
Eric S Goetzman, Bob B Zhang, Yuxun Zhang, Sivakama S Bharathi, Joanna Bons, Jacob Rose, Samah Shah, Keaton J Solo, Alexandra V Schmidt, Adam C Richert, Steven J Mullett, Stacy L Gelhaus, Krithika S Rao, Sruti S Shiva, Katherine E Pfister, Anne Silva Barbosa, Sunder Sims-Lucas, Steven F Dobrowolski, Birgit Schilling
Dicarboxylic fatty acids are generated in the liver and kidney in a minor pathway called fatty acid ω-oxidation. The effects of consuming dicarboxylic fatty acids as an alternative source of dietary fat have not been explored. Here, we fed dodecanedioic acid, a 12-carbon dicarboxylic (DC12), to mice at 20% of daily caloric intake for nine weeks. DC12 increased metabolic rate, reduced body fat, reduced liver fat, and improved glucose tolerance. We observed DC12-specific breakdown products in liver, kidney, muscle, heart, and brain, indicating that oral DC12 escaped first-pass liver metabolism and was utilized by many tissues...
April 30, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38687446/integrated-proteomics-and-protein-co-expression-network-analysis-identifies-novel-epileptogenic-mechanism-in-mesial-temporal-lobe-epilepsy
#39
JOURNAL ARTICLE
Arpna Srivastava, Priya Rajput, Manjari Tripathi, Poodipedi Sarat Chandra, Ramesh Doddamani, Mehar Chand Sharma, Sanjeev Lalwani, Jyotirmoy Banerjee, Aparna Banerjee Dixit
Over 50 million people worldwide are affected by epilepsy, a common neurological disorder that has a high rate of drug resistance and diverse comorbidities such as progressive cognitive and behavioural disorders, and increased mortality from direct or indirect effects of seizures and therapies. Despite extensive research with animal models and human studies, limited insights have been gained into the mechanisms underlying seizures and epileptogenesis, which has not translated into significant reductions in drug resistance, morbidities, or mortality...
April 30, 2024: Molecular Neurobiology
https://read.qxmd.com/read/38687312/serum-brain-derived-neurotrophic-factor-level-and-its-relation-with-cannabis-use-disorder-and-schizophrenia-a-cross-sectional-exploratory-study-in-patients-at-a-tertiary-care-hospital
#40
JOURNAL ARTICLE
Aishwariya Brigit George, Abhishek Gupta, Raka Jain, Mamta Sood, Siddharth Sarkar
BACKGROUND: Brain-derived neurotrophic factor (BDNF) has considerable relevance in neural growth and differentiation. It has been evaluated as a biomarker for individuals with various psychiatric disorders such as substance-related disorders and psychotic disorders. OBJECTIVE: The present study explored differences in the levels of BDNF (in serum) among subjects using cannabis (with and without schizophrenia). METHODS: This cross-sectional observational study compared the serum BDNF level in male subjects aged 18-45 years...
March 1, 2024: Indian Journal of Pharmacology
keyword
keyword
119208
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.